🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6258870

Gels for encapsulation of biological materials

The Board of Regents of the University of Texas System · Granted Tue Jul 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6251878

Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotectiv

The Board of Regents of the University of Texas System · Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6251871

P16 expression constructs and their application in cancer therapy

The Board of Regents of the University of Texas System · Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248351

Human PEA3 is a tumor suppressor for cancer cells

The Board of Regents of the University of Texas System · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6242418

Therapeutic uses of BPI protein products for human meningococcemia

The Board of Regents of the University of Texas System · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6231892

Compositions for coating microcapsules and other surfaces

The Board of Regents of the University of Texas System · Granted Tue May 15 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6210873

Methods and compositions for the priming of specific cytotoxic T-lymphocyte response

The Board of Regents of the University of Texas System · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6207690

Troglitazone compounds for treating climacteric and cancer

The Board of Regents of the University of Texas System · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6203793

Compositions and methods for treating thermal injury

The Board of Regents of the University of Texas System · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6201165

Transgenic animal models for cardiac hypertrophy and methods of use thereof

The Board of Regents of the University of Texas System · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6200597

Formulation and use of carotenoids in treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6197754

Suppression of tumor growth by a mini-E1A gene

The Board of Regents of the University of Texas System · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194176

Recombinant expression of proteins from secretory cell lines

The Board of Regents of the University of Texas System · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194481

Mechanically strong and transparent or translucent composites made using zirconium oxide n

The Board of Regents of the University of Texas System · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6184224

Antitumor dibenzofluorene derivatives

The Board of Regents of the University of Texas System · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6184254

Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors

The Board of Regents of the University of Texas System · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6172212

Pea3 is a tumor suppressor

The Board of Regents of the University of Texas System · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6171856

Methods and compositions relating to no-mediated cytotoxicity

The Board of Regents of the University of Texas System · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165484

EDTA and other chelators with or without antifungal antimicrobial agents for the preventio

The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165461

Tao protein kinases and methods of use therefor

The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165440

Radiation and nanoparticles for enhancement of drug delivery in solid tumors

The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165990

Antisense polynucleotide

The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6166193

Polynucleotides encoding MY1 receptor

The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6166079

DFMO for the treatment or prevention of cervical intraepithelial neoplasia

The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired